biobricks - FuturePlay Portfolio Company Details

biobricks is a biofabrication company developing OrganINK, a liquid dECM-based bioink, and GelCODE, a regenerative therapy for corneal ulcers. Bioink, composed of living cells and biocompatible materials, is essential for 3D bioprinting of tissues and organs, with applications in regenerative medicine and artificial organ development. OrganINK delivers top-tier performance in viscoelasticity, shape retention, and printing precision. Based on this technology, GelCODE provides high optical transparency while promoting rapid wound healing and tissue regeneration. Built on the world-class research of Dr. Jina Jang at POSTECH Graduate School of Medicine, BioBricks is emerging as a global leader in the bioink market.